- Home
- TKNO vs XBIT Comparison
TKNO vs XBIT Comparison
Compare TKNO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKNO
- XBIT
- Stock Information
- Founded
- TKNO 1996
- XBIT 2005
- Country
- TKNO United States
- XBIT United States
- Employees
- TKNO N/A
- XBIT N/A
- Industry
- TKNO Medicinal Chemicals and Botanical Products
- XBIT Pharmaceuticals and Biotechnology
- Sector
- TKNO Health Care
- XBIT Health Care
- Exchange
- TKNO Nasdaq
- XBIT Nasdaq
- Market Cap
- TKNO 244.7M
- XBIT 242.2M
- IPO Year
- TKNO 2021
- XBIT 2015
- Fundamental
- Price
- TKNO $4.92
- XBIT $7.48
- Analyst Decision
- TKNO Buy
- XBIT
- Analyst Count
- TKNO 2
- XBIT 0
- Target Price
- TKNO $5.00
- XBIT N/A
- AVG Volume (30 Days)
- TKNO 129.4K
- XBIT 52.4K
- Earning Date
- TKNO 11-07-2024
- XBIT 11-07-2024
- Dividend Yield
- TKNO N/A
- XBIT N/A
- EPS Growth
- TKNO N/A
- XBIT N/A
- EPS
- TKNO N/A
- XBIT N/A
- Revenue
- TKNO $34,940,000.00
- XBIT N/A
- Revenue This Year
- TKNO $3.22
- XBIT N/A
- Revenue Next Year
- TKNO $14.88
- XBIT N/A
- P/E Ratio
- TKNO N/A
- XBIT N/A
- Revenue Growth
- TKNO N/A
- XBIT N/A
- 52 Week Low
- TKNO $1.16
- XBIT $3.51
- 52 Week High
- TKNO $5.46
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- TKNO 55.60
- XBIT 56.26
- Support Level
- TKNO $4.47
- XBIT $7.05
- Resistance Level
- TKNO $4.93
- XBIT $7.93
- Average True Range (ATR)
- TKNO 0.40
- XBIT 0.57
- MACD
- TKNO -0.01
- XBIT 0.03
- Stochastic Oscillator
- TKNO 58.77
- XBIT 71.10
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.